| Year |
Citation |
Score |
| 2017 |
Bray MA, Gustafsdottir SM, Ljosa V, Singh S, Sokolnicki KL, Bittker JA, Bodycombe NE, Dancík V, Hasaka TP, Hon CS, Kemp MM, Li K, Walpita D, Wawer MJ, Golub TR, et al. A dataset of images and morphological profiles of 30,000 small-molecule treatments using the Cell Painting assay. Gigascience. PMID 28327978 DOI: 10.1093/Gigascience/Giw014 |
0.344 |
|
| 2016 |
Boskovic ZV, Kemp MM, Freedy AM, Viswanathan VS, Pop MS, Fuller JH, Martinez NM, Figuero Lazu SO, Hong JA, Lewis TA, Calarese D, Love JD, Vetere A, Almo SC, Schreiber SL, et al. Inhibition of zinc-dependent histone deacetylases with a chemically triggered electrophile. Acs Chemical Biology. PMID 27064299 DOI: 10.1021/Acschembio.6B00012 |
0.703 |
|
| 2014 |
Wawer MJ, Li K, Gustafsdottir SM, Ljosa V, Bodycombe NE, Marton MA, Sokolnicki KL, Bray MA, Kemp MM, Winchester E, Taylor B, Grant GB, Hon CS, Duvall JR, Wilson JA, et al. Toward performance-diverse small-molecule libraries for cell-based phenotypic screening using multiplexed high-dimensional profiling. Proceedings of the National Academy of Sciences of the United States of America. 111: 10911-6. PMID 25024206 DOI: 10.1073/Pnas.1410933111 |
0.397 |
|
| 2013 |
Gustafsdottir SM, Ljosa V, Sokolnicki KL, Anthony Wilson J, Walpita D, Kemp MM, Petri Seiler K, Carrel HA, Golub TR, Schreiber SL, Clemons PA, Carpenter AE, Shamji AF. Multiplex cytological profiling assay to measure diverse cellular states. Plos One. 8: e80999. PMID 24312513 DOI: 10.1371/Journal.Pone.0080999 |
0.399 |
|
| 2012 |
Yuan Y, Wang Q, Paulk J, Kubicek S, Kemp MM, Adams DJ, Shamji AF, Wagner BK, Schreiber SL. A small-molecule probe of the histone methyltransferase G9a induces cellular senescence in pancreatic adenocarcinoma. Acs Chemical Biology. 7: 1152-7. PMID 22536950 DOI: 10.1021/Cb300139Y |
0.399 |
|
| 2012 |
Kemp MM, Weïwer M, Koehler AN. Unbiased binding assays for discovering small-molecule probes and drugs. Bioorganic & Medicinal Chemistry. 20: 1979-89. PMID 22230199 DOI: 10.1016/J.Bmc.2011.11.071 |
0.73 |
|
| 2011 |
Kemp MM, Wang Q, Fuller JH, West N, Martinez NM, Morse EM, Weïwer M, Schreiber SL, Bradner JE, Koehler AN. A novel HDAC inhibitor with a hydroxy-pyrimidine scaffold. Bioorganic & Medicinal Chemistry Letters. 21: 4164-9. PMID 21696956 DOI: 10.1016/J.Bmcl.2011.05.098 |
0.688 |
|
| 2011 |
Wang Z, Flax LA, Kemp MM, Linhardt RJ, Baron MJ. Host and pathogen glycosaminoglycan-binding proteins modulate antimicrobial peptide responses in Drosophila melanogaster. Infection and Immunity. 79: 606-16. PMID 21078848 DOI: 10.1128/Iai.00254-10 |
0.463 |
|
| 2010 |
Kemp MM, Linhardt RJ. Heparin-based nanoparticles. Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology. 2: 77-87. PMID 20049832 DOI: 10.1002/Wnan.68 |
0.402 |
|
| 2009 |
Weïwer M, Chen CC, Kemp MM, Linhardt RJ. Synthesis and Biological Evaluation of Non-Hydrolizable 1,2,3-Triazole Linked Sialic Acid Derivatives as Neuraminidase Inhibitors. European Journal of Organic Chemistry. 2009. PMID 24223493 DOI: 10.1002/Ejoc.200900117 |
0.721 |
|
| 2009 |
Kemp MM, Kumar A, Mousa S, Dyskin E, Yalcin M, Ajayan P, Linhardt RJ, Mousa SA. Gold and silver nanoparticles conjugated with heparin derivative possess anti-angiogenesis properties. Nanotechnology. 20: 455104. PMID 19822927 DOI: 10.1088/0957-4484/20/45/455104 |
0.404 |
|
| 2009 |
Kemp MM, Kumar A, Clement D, Ajayan P, Mousa S, Linhardt RJ. Hyaluronan- and heparin-reduced silver nanoparticles with antimicrobial properties. Nanomedicine (London, England). 4: 421-9. PMID 19505245 DOI: 10.2217/Nnm.09.24 |
0.413 |
|
| 2009 |
Kemp MM, Kumar A, Mousa S, Park TJ, Ajayan P, Kubotera N, Mousa SA, Linhardt RJ. Synthesis of gold and silver nanoparticles stabilized with glycosaminoglycans having distinctive biological activities. Biomacromolecules. 10: 589-95. PMID 19226107 DOI: 10.1021/Bm801266T |
0.552 |
|
| 2009 |
Zhang Z, Park Y, Kemp MM, Zhao W, Im AR, Shaya D, Cygler M, Kim YS, Linhardt RJ. Liquid chromatography-mass spectrometry to study chondroitin lyase action pattern. Analytical Biochemistry. 385: 57-64. PMID 18992215 DOI: 10.1016/J.Ab.2008.10.014 |
0.717 |
|
| 2009 |
Weïwer M, Chen C, Kemp MM, Linhardt RJ. Synthesis and Biological Evaluation of Non-Hydrolyzable 1,2,3-Triazole-Linked Sialic Acid Derivatives as Neuraminidase Inhibitors (Eur. J. Org. Chem. 16/2009) European Journal of Organic Chemistry. 2009: 2587-2587. DOI: 10.1002/Ejoc.200990041 |
0.726 |
|
| 2008 |
Zhang Z, Weïwer M, Li B, Kemp MM, Daman TH, Linhardt RJ. Oversulfated chondroitin sulfate: impact of a heparin impurity, associated with adverse clinical events, on low-molecular-weight heparin preparation. Journal of Medicinal Chemistry. 51: 5498-501. PMID 18754653 DOI: 10.1021/Jm800785T |
0.698 |
|
| 2007 |
Sinnis P, Coppi A, Toida T, Toyoda H, Kinoshita-Toyoda A, Xie J, Kemp MM, Linhardt RJ. Mosquito heparan sulfate and its potential role in malaria infection and transmission. The Journal of Biological Chemistry. 282: 25376-84. PMID 17597060 DOI: 10.1074/Jbc.M704698200 |
0.52 |
|
| 2007 |
Hrtska SC, Kemp MM, Muñoz EM, Azizad O, Banerjee M, Raposo C, Kumaran J, Ghosh P, Linhardt RJ. Investigation of the mechanism of binding between internalin B and heparin using surface plasmon resonance. Biochemistry. 46: 2697-706. PMID 17305366 DOI: 10.1021/Bi062021X |
0.683 |
|
| 2006 |
Shao C, Zhang F, Kemp MM, Linhardt RJ, Waisman DM, Head JF, Seaton BA. Crystallographic analysis of calcium-dependent heparin binding to annexin A2. The Journal of Biological Chemistry. 281: 31689-95. PMID 16882661 DOI: 10.1074/Jbc.M604502200 |
0.568 |
|
| 2006 |
Muñoz E, Xu D, Kemp M, Zhang F, Liu J, Linhardt RJ. Affinity, kinetic, and structural study of the interaction of 3-O-sulfotransferase isoform 1 with heparan sulfate. Biochemistry. 45: 5122-8. PMID 16618101 DOI: 10.1021/Bi052403N |
0.723 |
|
| 2006 |
Muñoz E, Xu D, Avci F, Kemp M, Liu J, Linhardt RJ. Enzymatic synthesis of heparin related polysaccharides on sensor chips: rapid screening of heparin-protein interactions. Biochemical and Biophysical Research Communications. 339: 597-602. PMID 16310167 DOI: 10.1016/J.Bbrc.2005.11.051 |
0.733 |
|
| Show low-probability matches. |